EUVIMEDEUVIMED entdecken
Crossref

Biopolymer Silica Hybrids as Superior Nanocarriers for Anticancer Drug Delivery

Sumiya Iqbal iD, Shaista Ilyas iD, Aya A Ezzat iD, Menna Hassan iD, Samar Mansour iD, Sanjay Mathur iD

ACS Applied Bio Materials · 02.11.2026 · 9 (21) · 10343-10357

DOI: 10.1021/acsabm.6c01527 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 09.10.2026. Verfasst von Sumiya Iqbal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Inorganic and Materials Chemistry, University of Cologne , Greinstr. 650939Cologne, Germany. Hauptthemen laut MEDLINE: Silicon Dioxide, Doxorubicin, Antineoplastic Agents, Drug Carriers. Die Arbeit nennt 72 Literaturangaben. Gefördert von: Deutscher Akademischer Austauschdienst, Center for Molecular Medicine Cologne, University of Cologne.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liposomal carriers are widely used for anticancer drug delivery due to their biocompatible nature in the biological milieu. Liposome-based drugs often face premature leakage, uncontrolled release, and insufficient control over long-term drug availability. Here, we present poly(lactic-co-glycolic acid) (PLGA)-coated mesoporous silica nanocarriers (PLGA–mSiO2, polysilomes) as an efficient and stable alternative to PEGylated liposomes. Such hybrid transporters are capable of efficiently encapsulating both hydrophilic [doxorubicin (DOX)] and hydrophobic [tamoxifen (TAM)] drugs. Investigation on drug loading, release kinetics, cellular uptake, and therapeutic response confirms the superior drug encapsulation and delivery of polysilomes efficiently. In liposomes, TAM was localized within the lipid bilayer, whereas DOX was actively loaded into the aqueous core through a transmembrane pH gradient. While this architecture enabled coloading, liposomes showed rapid drug release and pronounced cytotoxicity. In contrast, the core–shell structure of PLGA–mSiO2 polysilome carriers retained hydrophilic DOX within the mesoporous silica core and hydrophobic TAM within the PLGA shell. This compartmentalization ensures higher encapsulation efficiencies of both DOX (77.3%) and TAM (60.5%), with loading capacities of 59.3 and 50.4%, respectively. The PLGA–silica interface is a degradable diffusion barrier, enabling pH-responsive sustained release under acidic conditions. Moreover, PLGA–mSiO2 showed enhanced cellular uptake in MDA-MB-231 breast cancer cells and prolonged (up to 144 h) suppression of cell viability. These results present PLGA-coated mesoporous silica nanocarriers as a promising alternative to liposomal delivery by converting rapid drug release into sustained therapeutic activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Silicon DioxideDoxorubicinAntineoplastic AgentsDrug CarriersBiocompatible MaterialsTamoxifenNanoparticlesHumansParticle SizeMaterials TestingCell SurvivalDrug Screening Assays, AntitumorPolylactic Acid-Polyglycolic Acid CopolymerCell Line, TumorLiposomes

Stichwörter der Autor:innen

PLGAcodeliverydoxorubicinliposomesmesoporous silicatamoxifentriple negative breast cancer

Substanzen

Silicon DioxideDoxorubicinAntineoplastic AgentsDrug CarriersBiocompatible MaterialsTamoxifenPolylactic Acid-Polyglycolic Acid CopolymerLiposomes

Autor:innen und Institutionen

  • Institute of Inorganic and Materials Chemistry, University of Cologne , Greinstr. 650939Cologne, Germany.
  • Center for Molecular Medicine Cologne (CMMC), University of Cologne, Robert-Koch-Str. 2150931Cologne, Germany.
  • Pharmaceutical Technology Department, German University in Cairo (GUC)11835Cairo, Egypt.
  • Faculty of Pharmaceutical Engineering and Technology, German International University (GIU)11351Cairo, Egypt.
  • Department of Metallurgical and Materials Engineering, Indian Institute of Technology Madras, Chennai600036, India.

ORCID-Profile: Sumiya Iqbal, Shaista Ilyas, Aya A Ezzat, Menna Hassan, Samar Mansour, Sanjay Mathur

Förderung

  • Deutscher Akademischer Austauschdienst
  • Center for Molecular Medicine Cologne, University of Cologne

Zitieren

APA

Iqbal, S., Ilyas, S., Ezzat, A. A., Hassan, M., Mansour, S., & Mathur, S. (2026). Biopolymer Silica Hybrids as Superior Nanocarriers for Anticancer Drug Delivery. ACS Applied Bio Materials, 9(21), 10343-10357. https://doi.org/10.1021/acsabm.6c01527

Vancouver

Iqbal S, Ilyas S, Ezzat AA, Hassan M, Mansour S, Mathur S. Biopolymer Silica Hybrids as Superior Nanocarriers for Anticancer Drug Delivery. ACS Applied Bio Materials. 2026;9(21):10343-10357. doi:10.1021/acsabm.6c01527

BibTeX
@article{Iqbal2026,
  author = {Iqbal, Sumiya and Ilyas, Shaista and Ezzat, Aya A and Hassan, Menna and Mansour, Samar and Mathur, Sanjay},
  title = {Biopolymer Silica Hybrids as Superior Nanocarriers for Anticancer Drug Delivery},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  volume = {9},
  number = {21},
  pages = {10343--10357},
  doi = {10.1021/acsabm.6c01527}
}
Kostenlos starten →